Providing for consideration of the bill (H.R. 1862) to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.

Cost and committee reports

Official records Congress.gov attaches to H.Res. 517.

• Congress.gov noteOn 9/19/2002, a motion was filed to discharge the Rules Committee from consideration of H.Res.517 a resolution providing for the consideration of H.R.1862. A discharge petition requires 218 signatures for further action. (Discharge Petition No. 107-11: text with signatures.)
  Source: Congress.gov, record updated April 7, 2025 ↗

  Evidence

  Field in the Congress.gov record

  notes

  Congress.gov bill record

  H.Res. 517, 107th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/107/hres/517

  Record last updated by Congress.gov

  April 7, 2025

  PORKER copy retrieved

  September 28, 2026

  Stored copy, SHA-256 of the file

  d79ba4e547a95ba4957e47e05ce4019dcbb73771260bca516d6e163d2197e1c3

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of April 7, 2025). Not every bill gets one.

From the Congress.gov bill record for H.Res. 517, last updated April 7, 2025. PORKER’s copy was retrieved September 28, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.